Memorial Sloan Kettering Cancer Center (MSK) researchers have discovered that innate immune signaling drives late cardiac toxicity after DNA-damaging cancer therapies. Their results, published in the ...

New leaders stepped into pivotal roles at MSK in 2025, bringing bold visions to advance clinical care, scientific research, immuno-oncology, and the emotional well-being of patients — collectively ...

The Society of Memorial Sloan-Kettering (MSK) held its 16th Annual Spring Ball on Thursday night, in the freshly redone ballroom of the Pierre Hotel, where 430 guests came out to support this ...

Memorial Sloan Kettering Cancer Center and health insurer Anthem Blue Cross and Blue Shield have reached a deal on payment rates, maintaining coverage of cancer services for thousands of patients in ...

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in motion plans for the entities to combine their respective expertise to ...

Tuesday morning, the nation’s largest insurance company, UnitedHealthcare and Memorial Sloan Kettering Cancer Center announced they had reached a multi-year agreement that will allow some 19,000 ...

TailorCare, a leading specialty value-based care organization providing scalable musculoskeletal (MSK) care navigation solutions, today released new research addressing one of the costliest health ...

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their ...

Dr. Andrea Cercek holds Maya, daughter of Kelly Spill, a participant in MSK’s groundbreaking immunotherapy trial. The treatment allowed Kelly to avoid surgery and preserve her ability to have children ...

Post-election politics were very much in the air among guests at the Society of Memorial Sloan Kettering Cancer Center’s fall party Wednesday night at The Plaza hotel. During cocktails, the din was so ...